相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Discovery of Potent and Selective PI3Kγ Inhibitors
Samuel L. Drew et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Class 1 PI3K Clinical Candidates and Recent Inhibitor Design Strategies: A Medicinal Chemistry Perspective
Aimie E. Garces et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Design and Synthesis of a Novel Series of Orally Bioavailable, CNS-Penetrant, Isoform Selective Phosphoinositide 3-Kinase γ (PI3Kγ) Inhibitors with Potential for the Treatment of Multiple Sclerosis (MS)
Jon H. Come et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
The next generation of PI3K-Akt-mTOR-pathway-inhibitors-in-breast cancer cohorts
Michael Mc Kenna et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2018)
The PI3K Pathway in Human Disease
David A. Fruman et al.
CELL (2017)
Discovery of imidazo[1,2-a]-pyridine inhibitors of pan-PI3 kinases that are efficacious in a mouse xenograft model
Wooseok Han et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Discovery and SAR of Novel 2,3-Dihydroimidazo[1,2-c]-quinazoline PI3K Inhibitors: Identification of Copanlisib (BAY 80-6946)
William J. Scott et al.
CHEMMEDCHEM (2016)
2,4,6-Triaminopyrimidine as a Novel Hinge Binder in a Series of PI3Kδ Selective Inhibitors
Leena Patel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
The Rational Design of Selective Benzoxazepin Inhibitors of the α-Isoform of Phosphoinositide 3-Kinase Culminating in the Identification of (S)-2-((2-(1-Isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)oxy)propanamide (GDC-0326)
Timothy P. Heffron et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Novel agents and associated toxicities of inhibitors of the PI3K/Akt/mTOR pathway for the treatment of breast cancer
S. Chia et al.
CURRENT ONCOLOGY (2015)
PI3K/AKT/mTOR pathway inhibitors: the ideal combination partners for breast cancer therapies?
Jame Abraham
EXPERT REVIEW OF ANTICANCER THERAPY (2015)
Discovery and Optimization of Pyrimidone Indoline Amide P13Kβ Inhibitors for the Treatment of Phosphatase and Tensin Homologue (PTEN)-Deficient Cancers
Victor Certal et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
PI3K and cancer: lessons, challenges and opportunities
David A. Fruman et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Assessing the performance of MM/PBSA and MM/GBSA methods. 4. Accuracies of MM/PBSA and MM/GBSA methodologies evaluated by various simulation protocols using PDBbind data set
Huiyong Sun et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2014)
Assessing the performance of MM/PBSA and MM/GBSA methods. 5. Improved docking performance using high solute dielectric constant MM/GBSA and MM/PBSA rescoring
Huiyong Sun et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2014)
Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation
Pascal Furet et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 2. Explicit Solvent Particle Mesh Ewald
Romelia Salomon-Ferrer et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2013)
Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 1. Generalized Born
Andreas W. Goetz et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2012)
Somatic mutations in PI3Kα: Structural basis for enzyme activation and drug design
Sandra B. Gabelli et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
PI3K/p110δ is a novel therapeutic target in multiple myeloma
Hiroshi Ikeda et al.
BLOOD (2010)
The p110δ structure: mechanisms for selectivity and potency of new PI(3)K inhibitors (vol 6, pg 117, 2010)
Alex Berndt et al.
NATURE CHEMICAL BIOLOGY (2010)
The p110δ structure: mechanisms for selectivity and potency of new PI(3)K inhibitors
Alex Berndt et al.
NATURE CHEMICAL BIOLOGY (2010)
Inhibitors of the PI3K/Akt/mTOR Pathway: New Hope for Breast Cancer Patients
Sandra E. Ghayad et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2010)
AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility
Garrett M. Morris et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
PTEN-deficient cancers depend on PIK3CB
Susan Wee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Jeffrey A. Engelman et al.
NATURE REVIEWS GENETICS (2006)
Exploiting the PI3K/AKT pathway for cancer drug discovery
BT Hennessy et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
High frequency of mutations of the PIK3CA gene in human cancers
Y Samuels et al.
SCIENCE (2004)
Development and testing of a general amber force field
JM Wang et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Exploring protein native states and large-scale conformational changes with a modified generalized born model
A Onufriev et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2004)
Langevin stabilization of molecular dynamics
JA Izaguirre et al.
JOURNAL OF CHEMICAL PHYSICS (2001)
分享论文
